相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Novel Chinese Coronavirus (2019-nCoV) Infections: challenges for fighting the storm
Matteo Bassetti et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2020)
Deep Vein Thrombosis in Hospitalized Patients With COVID-19 in Wuhan, China Prevalence, Risk Factors, and Outcome
Li Zhang et al.
CIRCULATION (2020)
Extremely High Incidence of Lower Extremity Deep Venous Thrombosis in 48 Patients With Severe COVID-19 in Wuhan
Bin Ren et al.
CIRCULATION (2020)
Pulmonary Embolism in Patients With COVID-19 Awareness of an Increased Prevalence
Julien Poissy et al.
CIRCULATION (2020)
Thrombotic risk in COVID-19: a case series and case-control study
Simon M. Stoneham et al.
CLINICAL MEDICINE (2020)
Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019
Thomas K. Maatman et al.
CRITICAL CARE MEDICINE (2020)
Coronavirus disease 2019: The harms of exaggerated information and non-evidence-based measures
John P. A. Ioannidis
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2020)
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
Julie Helms et al.
INTENSIVE CARE MEDICINE (2020)
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
Safiya Richardson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy
Giacomo Grasselli et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified?
Marco Cattaneo et al.
THROMBOSIS AND HAEMOSTASIS (2020)
ISTH interim guidance on recognition and management of coagulopathy in COVID-19: A comment
Christopher D. Barrett et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients
Jean-Francois Llitjos et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Incidence of venous thromboembolism in hospitalized patients with COVID-19
Saskia Middeldorp et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors
Mathieu Artifoni et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
Maximilian Ackermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Hospitalized COVID-19 Patients and Venous Thromboembolism A Perfect Storm
Alex C. Spyropoulos et al.
CIRCULATION (2020)
Comparison of Venous Thromboembolism Risks Between COVID-19 Pneumonia and Community-Acquired Pneumonia Patients
Fei Mei et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)
Coagulation Abnormalities and Thrombosis in Patients Infected With SARS-CoV-2 and Other Pandemic Viruses
Nigel Mackman et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)
COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection
Hanny Al-Samkari et al.
BLOOD (2020)
Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health System
Seda Bilaloglu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
The hazard of (sub)therapeutic doses of anticoagulants in non-critically ill patients with Covid-19: The Padua province experience
Raffaele Pesavento et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism
F. Galeano-Valle et al.
THROMBOSIS RESEARCH (2020)
Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis
F. A. Klok et al.
THROMBOSIS RESEARCH (2020)
Thrombotic complications of patients admitted to intensive care with COVID-19 at a teaching hospital in the United Kingdom
W. Thomas et al.
THROMBOSIS RESEARCH (2020)
Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels
P. Demelo-Rodriguez et al.
THROMBOSIS RESEARCH (2020)
Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy
Corrado Lodigiani et al.
THROMBOSIS RESEARCH (2020)
Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19
Girish N. Nadkarni et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaboration
Tobias Tritschler et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Image-proven thromboembolism in patients with severe COVID-19 in a tertiary critical care unit in the United Kingdom
Michael J. R. Desborough et al.
THROMBOSIS RESEARCH (2020)
Patients with isolated pulmonary embolism in comparison to those with deep venous thrombosis. Differences in characteristics and clinical evolution
Gualtiero Palareti et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2019)
American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients
Holger J. Schunemann et al.
BLOOD ADVANCES (2018)
Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients REPLY
Alexander T. Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients
Alexander T. Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Prevention of VTE in Nonsurgical Patients Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Susan R. Kahn et al.
CHEST (2012)
Dalteparin versus Unfractionated Heparin in Critically Ill Patients
Deborah Cook et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Apixaban versus Enoxaparin for Thromboprophylaxis in Medically Ill Patients
Samuel Z. Goldhaber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
An open-label comparison of the efficacy and safety of certoparin versus unfractionated heparin for the prevention of thromboembolic complications in acutely ill medical patients: CERTAIN
Sebastian M. Schellong et al.
EXPERT OPINION ON PHARMACOTHERAPY (2010)
A randomized, double-blind study of certoparin vs. unfractionated heparin to prevent venous thromboembolic events in acutely ill, non-surgical patients: CERTIFY Study
H. Riess et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients
A Leizorovicz et al.
CIRCULATION (2004)
分享论文
